All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVARTIS · Use innovative science and technology to discover & develop breakthrough treatments

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

Lobbying activity 3

Budget/Appropriations

Federal budget issues

Health Issues

MINI Act, IRA, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies, EPIC Act, supply chain

Medicare/Medicaid

bio pharmaceutical reimbursement issues, IRA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.